A lower expression of LTF has been shown in tumours such as prostate cancer (CaP), NPC, osteosarcoma, clear cell renal cell carcinoma (ccRCC) and OSCC [21,22,23,24,25,26]. This evidence concerns the gene LTF and prostate carcinoma.